FDA Approves Daraxonrasib (Rasonque): A Breakthrough Treatment for Pancreatic Cancer
A New Era for One of the Deadliest Cancers The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque) — a first-in-class...
43 articles
A New Era for One of the Deadliest Cancers The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque) — a first-in-class...
A Landmark Moment in Cancer Treatment Drugmakers Moderna and Merck have announced that a personalized mRNA cancer vaccine, given alongside the immunotherapy drug Keytruda, significantly...
Personalized mRNA Cancer Vaccine Shows Breakthrough Results in Melanoma Trial A personalized mRNA cancer vaccine developed by pharmaceutical giants Merck and Moderna has shown significant...
The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 and older — just in time...
Ebola Outbreak 2026: DRC Death Toll Passes 2,000 as WHO Warns of Deadliest Epidemic on Record The Ebola outbreak in the Democratic Republic of the...
Scientists Identify a New Ebola Variant in the 2026 DRC–Uganda Outbreak Researchers have identified a genetically distinct new Ebola variant behind the 2026 Democratic Republic...
A sweeping new review of more than 350 studies suggests that eating less protein could slow aging and improve long-term health — and that the...
The Ebola outbreak in the Democratic Republic of the Congo (DRC) has become the largest in the country’s history — and one of the fastest-growing...
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing power of semaglutide — the active ingredient in Ozempic — without the...
WHO Releases Updated Guidelines: Up to 45% of Dementia Risk Can Be Prevented or Delayed The World Health Organization (WHO) has released updated guidelines on...